Author

Selene Ceriotti

Observed name: S. Ceriotti

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, The San Raffaele Telethon Institute for Gene Therapy

Observed institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, The San Raffaele Telethon Institute for Gene Therapy

OpenAlex ID: A5111283321

A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB

2024 · Stefania Crippa, Gaia Alberti, et al. · Molecular Therapy — Methods & Clinical Development · 4

PATIENT-DERIVED HSPC GENE THERAPY TO MITIGATE IMMUNE DYSFUNCTION AND PROTECT β CELLS IN A HUMANIZED WOLFRAM SYNDROME MOUSE MODEL

2026 · G. Siracusano, S. Ceriotti, et al. · Cytotherapy

Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease

2026 · Margherita Berti, Selene Ceriotti, et al. · Disease Models & Mechanisms

Works count: 3

Citation count: 4

H-index: 1

I10-index: